Hühneraugenpflaster

Salicylic acid, the active ingredient in Hühneraugenpflaster, is a keratolytic presented as a plaster for topical use. It exfoliates hyperkeratotic skin to facilitate removal of corns and calluses in individuals with localized lesions and is manufactured under EU quality standards as an over‑the‑counter product.

GNH USA supplies Hühneraugenpflaster as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Salicylic acid in Hühneraugenpflaster acts on hyperkeratotic skin conditions, providing keratolytic therapy.

Corn (clavus): removal of thickened skin lesions on the toes or feet Callus: reduction of hardened skin on pressure points Hyperkeratosis: softening of localized excess keratin

Topical application of salicylic acid may cause local skin reactions.

Common Side Effects: - Skin irritation or mild redness - Itching or burning sensation at the application site - Peeling or flaking of treated skin - Dryness or mild scaling - Mild discomfort during wear - Temporary discoloration of surrounding skin

Serious or Rare Side Effects: - Allergic contact dermatitis with swelling and vesicles - Ulceration or deep skin erosion - Severe pain or necrosis of the treated area - Secondary bacterial or fungal infection - Systemic salicylate toxicity (rare with extensive use) - Persistent hyperpigmentation

When using Hühneraugenpflaster, consider the following precautions to minimise adverse events.

Apply to intact skin: avoid broken or inflamed areas Allergy assessment: discontinue if hypersensitivity occurs Age limitation: use with caution in children under 12 years Pregnancy: avoid unless benefit outweighs potential risk Concurrent keratolytics: do not combine with other salicylic‑acid products Store at room temperature: keep in original packaging, protect from moisture and heat

Salicylic acid can interact with certain topical and systemic agents.

Major Interactions (Avoid): - Other topical salicylates: concurrent use may increase systemic absorption - Occlusive dressings: covering the plaster can enhance drug uptake and toxicity

Moderate Interactions (Monitor Closely): - Topical retinoids: may increase local irritation - Topical corticosteroids: may reduce keratolytic efficacy - Systemic salicylates (e.g., aspirin): monitor for cumulative salicylate levels